4//SEC Filing
REINHARDT MAX 4
Accession 0001209191-22-035229
CIK 0001396814other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 7:40 PM ET
Size
11.4 KB
Accession
0001209191-22-035229
Insider Transaction Report
Form 4
REINHARDT MAX
President
Transactions
- Award
Common Stock
2022-06-08+7,950→ 32,250 total - Award
Stock Option (Right to Buy)
2022-06-08+19,900→ 19,900 totalExercise: $59.39Exp: 2032-06-08→ Common Stock (19,900 underlying) - Sale
Common Stock
2022-06-06$61.37/sh−2,817$172,891→ 26,833 total - Sale
Common Stock
2022-06-07$62.00/sh−2,433$150,846→ 24,400 total
Footnotes (4)
- [F1]Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F3]Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
- [F4]The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.
Documents
Issuer
Pacira BioSciences, Inc.
CIK 0001396814
Entity typeother
Related Parties
1- filerCIK 0001780058
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 7:40 PM ET
- Size
- 11.4 KB